Valencia, Calif. — October 29, 2025 — Leads & Copy —
AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) will release its third quarter 2025 financial results after the U.S. financial markets close on Thursday, November 6, 2025. A conference call and webcast will be held that day at 1:30 p.m. Pacific Time (Friday, November 7, 2025, at 8:30 a.m. Australian Eastern Daylight Time) to discuss the results and recent business highlights.
The live webcast will be available on the AVITA Medical website. A replay will be available shortly after the live event.
AVITA Medical® is a therapeutic acute wound care company delivering transformative solutions. Its RECELL® System is approved by the U.S. Food and Drug Administration for thermal burn and trauma wounds. In the U.S., AVITA Medical also holds the rights to manufacture and market PermeaDerm® and to market Cohealyx™.
In international markets, the RECELL System is approved to promote skin healing in a range of applications, including thermal burn and trauma wounds, with regulatory clearances in Europe, Australia, and Japan.
Ben Atkins
Phone +1-805 341 1571
investor@avitamedical.com
media@avitamedical.com
Source: AVITA Medical, Inc.
